Search clinical trials for: oestrogen

Total 2891 results

Massachusetts General Hospital

Active, not recruiting

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Osteoporosis | Osteoporosis, Postmenopausal

United States
Ain Shams Maternity Hospital

Unknown

Clomiphene Citrate Stair-Step Protocol

Polycystic Ovary

Egypt
Shionogi
QuatRx Pharmaceuticals

Completed

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Atrophy | Vaginal Diseases
Stanley Medical Research Institute

Completed

Tamoxifen in Treatment of Acute Mania

Bipolar Disorder

Turkey
European Institute of Oncology

Completed

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

Breast Cancer

Italy
University Magna Graecia

Withdrawn

Clomiphene Citrate in Infertile PCOS Patients

Polycystic Ovary Syndrome | Infertility

Italy
Federal University of São Paulo

Completed

Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

Hypogonadotropic Hypogonadism | Prolactinoma

Brazil
University of Parma

Unknown

Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis

Retroperitoneal Fibrosis

Italy
MedSIR

Recruiting

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (EMPRESS)

Breast Cancer | Breast Cancer, Early-Onset

Spain, France
Sanofi
European Organisation for Research and Treatment of Cancer - EORTC; Alliance... and other collaborators

Terminated

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity (AMEERA-6)

Breast Cancer

Chile, China
Veru Inc.

Completed

Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer

Prostate Cancer Metastatic

United States
University of Illinois at Chicago

Withdrawn

Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism

Hypogonadism | Non Obstructive Azoospermia

Spain
University Hospital Birmingham

Unknown

Tamoxifen in Treating Women With Breast Cancer

Breast Cancer

United Kingdom
National Medical Research Council (NMRC), Singapore

Completed

Tamoxifen in Treating Patients With Primary Liver Cancer

Liver Cancer

New Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
Fundació Privada Eugin

Completed

Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles (CLOFA)

Female Infertility

Spain
Milton S. Hershey Medical Center
Mayo Clinic

Completed

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

Infertility

United States
National Taiwan University Hospital
Mackay Memorial Hospital; Kaohsiung Medical University; Tri-Service General Hospital and other collaborators

Recruiting

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Breast Ductal Carcinoma in Situ

Taiwan
Hospices Civils de Lyon

Not yet recruiting

Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells (CLOMINOA)

Azoospermia, Nonobstructive

France
BHR Pharma, LLC

Terminated

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue (4WARD)

Mammographic Breast Density

United States, Germany, Spain
Bagcilar Training and Research Hospital

Completed

Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone Levels

Unexplained Infertility | Ovulation Disorder

Turkey
Baylor College of Medicine
National Cancer Institute (NCI)

Completed

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors (BCTamoxifen)

Bladder Cancer

United States
Universitair Ziekenhuis Brussel

Completed

Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles (cc versus FSH)

Infertility

Belgium
University of Texas Southwestern Medical Center
Pfizer; University of Alabama at Birmingham; Women and Infants Hospital of Rhode...

Completed

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen (IMPROVE)

Pelvic Organ Prolapse | Pelvic Floor Disorders | Cystocele | Uterine Prolapse | Vaginal Vault Prolapse | Vaginal Prolapse | Urogenital Prolapse

United States
Viramal Limited
Simbec Research

Recruiting

Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

Menopause

United Kingdom
ASCEND Therapeutics
Solvay Pharmaceuticals

Completed

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Postmenopausal Symptoms

United States
Frederic Amant
Kom Op Tegen Kanker; FWO Research Fund Flanders

Recruiting

FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study (FUCHSia)

Endometrial Cancer | Endometrial Stromal Sarcoma | Sex Cord Stromal Tumor | Adenosarcoma of Uterus | Leiomyosarcoma Uterus | Serous Ovarian Tumor

Belgium
AstraZeneca

Completed

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced or

Korea, Republic of
Fudan University

Unknown

The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer

Breast Neoplasms
Mackay Memorial Hospital

Recruiting

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Urinary Bladder, Overactive | Effect of Drug

Taiwan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Soy Estrogen Alternative Study (SEA)

Heart Diseases | Cardiovascular Diseases | Uterine Diseases | Endometrial Hyperplasia | Menopause | Menopausal Complaints
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

Estrogen Replacement Therapy
Dr. Reddy's Laboratories SAS

Recruiting

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

Breast Neoplasm Female

Colombia
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Breast Cancer

United States
AstraZeneca

Completed

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Endometrial Carcinoma

Germany
Children's Hospital Medical Center, Cincinnati
Patty Brisben Foundation For Women's Sexual Health

Completed

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

Primary Ovarian Insufficiency

United States
Georgetown University

Terminated

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

United States
Andrea DeCensi
European Institute of Oncology; Associazione Italiana per la Ricerca sul Cancro

Active, not recruiting

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up (TAM-01)

Breast Neoplasms | Carcinoma, Intraductal, Noninfiltrating | Recurrence, Local Neoplasm | Atypical Hyperplasia

Italy
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; NCIC Clinical Trials Group; Cancer...

Completed

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Breast Cancer

United States, Canada
Oregon Health and Science University
Merck Women's Health Investigator Initiated Studies Program

Completed

Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users (Tamoxifen/BTB)

Bleeding | Breakthrough Bleeding | Implants

United States
Felipe Henning Gaia Duarte

Completed

Clomiphene Citrate for Treatment of Acromegaly

Acromegaly
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism

Obesity | Hypoandrogenism

Brazil
National Cancer Institute (NCI)

Completed

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Glioma

United States
Shionogi
Hormos Medical; QuatRx Pharmaceuticals

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women

Atrophy | Vaginal Diseases
National Cancer Institute (NCI)

Completed

Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Eli Lilly and Company

Completed

Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Canada, United States
AEterna Zentaris

Completed

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Non Small Cell Lung Cancer | Metastatic Breast Cancer | Solid Tumors | Sarcomas
Repros Therapeutics Inc.

Completed

Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism

Effect of Treatment on Bone Mineral Density

United States
University of Wisconsin, Madison

Completed

Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?

Osteoporosis

United States
Repros Therapeutics Inc.

Completed

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)

Search clinical trials for: oestrogen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations